Please assess the completion status of the following clinical trial:

Trial Title: GORE Embolic Protection With Reverse Flow

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Carotid stenosis requiring revascularization and indicating either symptomatic status, with carotid stenosis ≥ 50% OR asymptomatic status with carotid stenosis ≥ 80%~* Target lesion is located in one of the following:(a) internal carotid artery (ICA) (b) bifurcation (c) common carotid artery (CCA) proximal to the bifurcation~* At Anatomic risk for adverse events from CEA (e.g. restenosis after a prior CEA) OR at Co-morbid risk for adverse events from CEA (e.g., unstable angina with ECG changes)~Exclusion Criteria:~* Recent surgical procedure within 30 days before or after the stent procedure~* Uncontrolled sensitivity to contrast media~* Renal Insufficiency~* Recent evolving, acute stroke within 21 days of study evaluation~* Myocardial infarction within 72 hours prior to stent procedure~* History of a prior major ipsilateral stroke with residual neurological deficits likely to confound the neurological assessments (e.g., NIHSS)~* Neurological deficits not due to stroke likely to confound the neurological assessments (e.g., NIHSS)~Angiographic Exclusion Criteria:~* Isolated ipsilateral hemisphere leading to subject intolerance to reverse flow~* Total occlusion of the ipsilateral carotid artery~* Pre-existing stent in the ipsilateral carotid artery OR the contralateral carotid artery that extends into the aortic arch~* Presence of a filling defect, thrombus, occlusion or string sign in the target vessel~* Severe lesion calcification restricting stent deployment~* Carotid stenosis located distal to target stenosis that is more severe than target stenosis~* \> 50% stenosis of the CCA proximal to target vessel~* Known mobile plaque in the aortic arch

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- GFRS Pivotal Subjects (Type: EXPERIMENTAL): All non-training subjects using the GORE Flow Reversal System for embolic protection during carotid artery stenting (all subjects other than first two subjects accounted for in Training Cases).

Based on this trial design, predict the completion outcome and termination type (if applicable).